WNK2 and breast cancer: Additionally, in contrast to the results reported for breast cancer cells [31], examination of mitogen-activated protein kinase (MAPK) signaling pathways showed TS markedly increased phospho-ERK1/2 levels in a dose-dependent fashion in HM cells (Fig. 3D).